US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist

0.000
0.0000.00%

Close Jul 5 09:30 ET

0Market Cap0.00P/E (TTM)

Actuate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

2.08%-5.25M

-21.53%-21.63M

-5.36M

-17.79M

Net income from continuing operations

-57.41%-8.3M

-22.74%-24.74M

---5.27M

---20.16M

Operating gains losses

737.05%32.52K

318.22%79.82K

---5.1K

---36.58K

Other non cash items

1,675.06%505.08K

169.39%43.64K

--28.45K

--16.2K

Change In working capital

1,376.66%2.36M

48.56%2.57M

---185.07K

--1.73M

-Change in prepaid assets

-1,679.92%-82.87K

87.51%-3.16K

--5.25K

---25.3K

-Change in payables and accrued expense

1,385.02%2.45M

46.60%2.58M

---190.31K

--1.76M

Cash from discontinued investing activities

Operating cash flow

2.08%-5.25M

-21.53%-21.63M

---5.36M

---17.79M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

76.88%4.36M

-78.53%4.13M

2.46M

19.26M

Net issuance payments of debt

--4.5M

----

--0

----

Net preferred stock issuance

--0

-78.53%4.13M

--2.46M

--19.26M

Net other financing activities

---142.77K

----

----

----

Cash from discontinued financing activities

Financing cash flow

76.88%4.36M

-78.53%4.13M

--2.46M

--19.26M

Net cash flow

Beginning cash position

-85.53%2.96M

7.70%20.45M

--20.45M

--18.99M

Current changes in cash

69.25%-890.35K

-1,296.78%-17.49M

---2.9M

--1.46M

End cash Position

-88.22%2.07M

-85.53%2.96M

--17.55M

--20.45M

Free cash flow

2.08%-5.25M

-21.53%-21.63M

---5.36M

---17.79M

Currency Unit

USD

USD

USD

USD

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	2.08%-5.25M	-21.53%-21.63M	-5.36M	-17.79M
Net income from continuing operations	-57.41%-8.3M	-22.74%-24.74M	---5.27M	---20.16M
Operating gains losses	737.05%32.52K	318.22%79.82K	---5.1K	---36.58K
Other non cash items	1,675.06%505.08K	169.39%43.64K	--28.45K	--16.2K
Change In working capital	1,376.66%2.36M	48.56%2.57M	---185.07K	--1.73M
-Change in prepaid assets	-1,679.92%-82.87K	87.51%-3.16K	--5.25K	---25.3K
-Change in payables and accrued expense	1,385.02%2.45M	46.60%2.58M	---190.31K	--1.76M
Cash from discontinued investing activities
Operating cash flow	2.08%-5.25M	-21.53%-21.63M	---5.36M	---17.79M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	76.88%4.36M	-78.53%4.13M	2.46M	19.26M
Net issuance payments of debt	--4.5M	----	--0	----
Net preferred stock issuance	--0	-78.53%4.13M	--2.46M	--19.26M
Net other financing activities	---142.77K	----	----	----
Cash from discontinued financing activities
Financing cash flow	76.88%4.36M	-78.53%4.13M	--2.46M	--19.26M
Net cash flow
Beginning cash position	-85.53%2.96M	7.70%20.45M	--20.45M	--18.99M
Current changes in cash	69.25%-890.35K	-1,296.78%-17.49M	---2.9M	--1.46M
End cash Position	-88.22%2.07M	-85.53%2.96M	--17.55M	--20.45M
Free cash flow	2.08%-5.25M	-21.53%-21.63M	---5.36M	---17.79M
Currency Unit	USD	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall